Four Cancer Clinical Trials Advance with Blessing of FDA

Several biopharma companies celebrate the U.S. Food and Drug Administration’s approval for clinical trials involving therapeutics for cancer treatment, including Sonnet BioTherapeutics and Adagene Read on for more.